克隆性血液形成和癌症的遗传和环境风险
Stephanie Franco1, Lucy A Godley1,2
1Department of Medicine, Northwestern Medicine, Chicago, IL, USA.
The Journal of experimental medicine
|December 3, 2024
概括
克隆性血液形成 (CH) 涉及随着年龄的增长,血液细胞中体变异的积累. 这一过程增加了患恶性瘤和其他疾病的风险,为癌症预防提供了新的途径.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 衰老的衰老 衰老的衰老
背景情况:
- 随着年龄的增长,体变异在器官中积累起来,这是由细胞应激下的积极选择驱动的.
- 克隆造血 (clonal hematopoiesis,CH) 是血液造血克隆的扩张,在没有恶性瘤的个体中具有癌症相关的变异.
- 通常涉及的基因包括DNMT3A,TET2和ASXL1.1.
研究的目的:
- 探索遗传和环境因素,使个体易患CH.
- 了解CH如何驱动癌症的进展.
- 确定干预机会,改善癌症风险分层和治疗策略.
主要方法:
- 在血液细胞中对体变异的分析.
- 对CH的遗传和环境风险因素的调查.
- 探索CH在癌症进展和治疗结果中的作用.
主要成果:
- 血结合是血液形成区中常见的与年龄相关的过程.
- 血栓炎症与血液和固体恶性瘤,心血管和炎症疾病的风险增加有关.
- 特定的变异特征可能与遗传和环境倾向有关.
结论:
- 冠状病毒对包括癌症在内的各种疾病具有重大风险.
- 了解CH可以改善癌症风险评估和预防策略.
- 癌症治疗影响癌症治疗策略和患者在癌症护理中的结果.
相关概念视频
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Cancers Originate from Somatic Mutations in a Single Cell
11.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.6K
Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K


